Table 3.
Characterization of endothelin-1 (ET-1) induced vasoconstriction
Normal | DMD | |
---|---|---|
Control (normal=6, DMD=6) | ||
Maximum tension, g | 7.14 ± 0.71 | 5.69 ± 0.47 |
Maximum specific tension, g/mm2 | 1.70 ± 0.15 | 2.17 ± 0.25 |
Tension at the maximum ET-1 concentration, g | 6.98 ± 1.05 | 2.89 ± 0.66* |
Specific tension at the maximum ET-1 concentration, g/mm2 | 1.64 ± 0.18 | 1.09 ± 0.29 |
EC50, Log M | −7.98 ± 0.06 | −7.85 ± 0.18 |
Denuded (normal=6, DMD=6) | ||
Maximum tension, g | 5.93 ± 1.18 | 4.15 ± 0.44α |
Maximum specific tension, g/mm2 | 1.37 ± 0.20α | 1.58 ± 0.25 |
Tension at the maximum ET-1 concentration, g | 5.71 ± 1.45 | 2.37 ± 0.63 |
Specific tension at the maximum ET-1 concentration, g/mm2 | 1.31 ± 0.25 | 0.89 ± 0.26 |
EC50, Log M | −8.02 ± 0.08 | −7.96 ± 0.12 |
L-NAME (normal=6, DMD=6) | ||
Maximum tension, g | 7.85 ± 0.80 | 5.83 ± 0.53 |
Maximum specific tension, g/mm2 | 1.86 ± 0.16 | 2.26 ± 0.36 |
Tension at the maximum ET-1 concentration, g | 7.46 ± 1.10 | 2.94 ± 0.47* |
Specific tension at the maximum ET-1 concentration, g/mm2 | 1.75 ± 0.18 | 1.14 ± 0.23 |
EC50, Log M | −7.98 ± 0.07 | −7.81 ± 0.18 |
L-NAME + Indomethacin (normal=6, DMD=6) | ||
Maximum tension, g | 9.21 ± 1.24 | 7.06 ± 0.77 |
Maximum specific tension, g/mm2 | 2.17 ± 0.22 | 2.73 ± 0.47 |
Tension at the maximum ET-1 concentration, g | 8.27 ± 1.76 | 3.42 ± 0.53* |
Specific tension at the maximum ET-1 concentration, g/mm2 | 1.91 ± 0.29 | 1.25 ± 0.18 |
EC50, Log M | −7.97 ± 0.05 | −7.87 ± 0.13 |
Mean ± SEM
EC50, Half-maximal effective concentration
L-NAME, Nω-Nitro-L-arginine methyl ester hydrochloride
Significantly different from the normal group in the same row.
Significantly different from the L-NAME/Indomethacin group in the same column.